HCMT
MRNA icon

Highland Capital Management (Tennessee)’s Moderna MRNA Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,408
Closed -$253K – 301
2022
Q4 		$253K Buy
+1,408
New +$230K 0.02% 323
2022
Q1 		– Sell
-3,471
Closed -$882K – 346
2021
Q4 		$882K Buy
+3,471
New +$1.01M 0.05% 249
2020
Q1 		– Sell
-62,729
Closed -$1.23M – 324
2019
Q4 		$1.23M Buy
+62,729
New +$1.11M 0.09% 206
2019
Q3 		– Sell
-54,747
Closed -$801K – 322
2019
Q2 		$801K Buy
+54,747
New +$1.18M 0.06% 236

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Highland Capital Management (Tennessee)'s MRNA Position: Q1 2023 in Review

Highland Capital Management (Tennessee) sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,408 shares — an estimated $253K sold.

Highland Capital Management (Tennessee) first reported a position in MRNA in Q2 2019 and held it in 4 quarters. The position peaked at $1.23M in Q4 2019. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Highland Capital Management (Tennessee) reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 1,408 Moderna shares in Q1 2023, an estimated $253K.
  • Highland Capital Management (Tennessee) first reported a position in Moderna in Q2 2019 and held it in 4 quarters.
  • Highland Capital Management (Tennessee)'s Moderna position peaked at $1.23M in Q4 2019.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2023, filed 11 May 2023.